نتائج البحث - Hiroyuki Ida

  • يعرض 1 - 6 نتائج من 6
تنقيح النتائج
  1. 1
    Metabolomic Profiling of Pompe Disease-Induced Pluripotent Stem Cell-Derived Cardiomyocytes Reveals That Oxidative Stress Is Associated with Cardiac and Skeletal Muscle Pathology

    Metabolomic Profiling of Pompe Disease-Induced Pluripotent Stem Cell-Derived Cardiomyocytes Reveals That Oxidative Stress Is Associated with Cardiac and Skeletal Muscle Pathology حسب Yohei Sato, Hiroshi Kobayashi, Takashi Higuchi, Yohta Shimada, Hiroyuki Ida, Toya Ohashi

    منشور في 2016
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Increased food allergy and vitamin <scp>D</scp>: Randomized, double‐blind, placebo‐controlled trial

    Increased food allergy and vitamin <scp>D</scp>: Randomized, double‐blind, placebo‐controlled trial حسب Chihiro Norizoe, Naoe Akiyama, Takaaki Segawa, Hiroshi Tachimoto, Hidetoshi Mezawa, Hiroyuki Ida, Mitsuyoshi Urashima

    منشور في 2013
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Disease modeling and lentiviral gene transfer in patient-specific induced pluripotent stem cells from late-onset Pompe disease patient

    Disease modeling and lentiviral gene transfer in patient-specific induced pluripotent stem cells from late-onset Pompe disease patient حسب Yohei Sato, Hiroshi Kobayashi, Takashi Higuchi, Yohta Shimada, Takumi Era, Shigemi Kimura, Yoshikatsu Eto, Hiroyuki Ida, Toya Ohashi

    منشور في 2015
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Once- versus twice-daily dosing of eliglustat in adults with Gaucher disease type 1: The Phase 3, randomized, double-blind EDGE trial

    Once- versus twice-daily dosing of eliglustat in adults with Gaucher disease type 1: The Phase 3, randomized, double-blind EDGE trial حسب Joel Charrow, Cristina Fraga, Xuefan Gu, Hiroyuki Ida, Nicola Longo, Elena Lukina, Alexandre Nonino, Sebastiaan J.M. Gaemers, Marie-Hélène Jouvin, Jing Li, Yaoshi Wu, Yong Xue, Michel Peterschmitt

    منشور في 2018
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    N-Octyl-β-valienamine up-regulates activity of F213I mutant β-glucosidase in cultured cells: a potential chemical chaperone therapy for Gaucher disease

    N-Octyl-β-valienamine up-regulates activity of F213I mutant β-glucosidase in cultured cells: a potential chemical chaperone therapy for Gaucher disease حسب Hou Lin, Yuko Sugimoto, Yuki Ohsaki, Haruaki Ninomiya, Akira Oka, Miyako Taniguchi, Hiroyuki Ida, Yoshikatsu Eto, Seiichiro Ogawa, Yumi Matsuzaki, Miwa Sawa, Takehiko Inoue, Katsumi Higaki, Eiji Nanba, Kousaku Ohno, Yoshiyuki Suzuki

    منشور في 2004
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Venglustat combined with imiglucerase for neurological disease in adults with Gaucher disease type 3: the LEAP trial

    Venglustat combined with imiglucerase for neurological disease in adults with Gaucher disease type 3: the LEAP trial حسب Raphael Schiffmann, Timothy M. Cox, Jean-François Dedieu, Sebastiaan J.M. Gaemers, Julia B. Hennermann, Hiroyuki Ida, Eugen Mengel, Pascal Minini, Pramod K. Mistry, Petra B. Musholt, David Scott, Jyoti Sharma, Michel Peterschmitt

    منشور في 2022
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: